ISSN 1016-5169 | E-ISSN 1308-4488
pdf
Current Problems in Thrombolytic Treatment in Acute Myocyardial Infarction [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 1993; 21(2): 127-131

Current Problems in Thrombolytic Treatment in Acute Myocyardial Infarction

Güneş AKGÜN1

Results obtained in the treatment with three different types of plasminogen activators in patients with acute myocardial infarction were briefly reviewed. Reocclusion or the reperfused coronary artery, particularly during the first hour, remains a major problem. The limitations and value of antithrombotic and antiaggregant treatment (heparin and aspirin) were discussed. It was pointed out that a better organization should be sought to enable earlier arrival of acutely ischemic patients to the hospitals with the purpose of exposing a greater proportion of patients with acute myocardial infarction to the benefits of thrombolytic therapy.

Keywords: Acute myocardial infarction, antiplatelet therapy, plasminogen activator thrombolysis

How to cite this article
Güneş AKGÜN. Current Problems in Thrombolytic Treatment in Acute Myocyardial Infarction. Turk Kardiyol Dern Ars. 1993; 21(2): 127-131
Manuscript Language: Turkish


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.